FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

ABBOTINDIA Share Price Discussion

Abbott India Ltd.
NSE: ABBOTINDIA | BSE: 500488 | ISIN: INE358A01014 | Sector: Pharmaceuticals and health care

ABBOTINDIA Rating

5/5 (2 Ratings)
ABBOTINDIA Share Price *
16,171.6 -65.5 (-0.4%)
* (quote may be delayed)
Find answers to all your questions on live ABBOTINDIA message board: Is ABBOTINDIA buy or sell? Should I buy ABBOTINDIA shares? Why are ABBOTINDIA shares falling? Should I invest in ABBOTINDIA stock?

You can also check ABBOTINDIA share price target recommended by brokerages.

ABBOTINDIA Discussion Forum

ABBOTINDIA

Type
Buy
Instrument
ABBOTINDIA
Entry Price
₹16,395
Price@Trade
₹16,399.95
Target Price
₹17,400
Stop Price
₹15,700
Valid Till
Mar 27, 2020 3:20 AM
Margin
₹16,395 approx for 1 Qty
Status
Active
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Yesterday 3:12 AM

Update
Trade Entered
Entry Price
₹16,395
@newsbot • Reputation: 2,356
Value investing: Top 10 stocks based on Warren Buffett's investment methodology
Warren Buffett has been a role model for investors across the world, his teachings and methods will always be applied and his ideas will have a lasting impact on the capital markets.
Moneycontrol
Like
reply
Reply

Jawed Zia quits Abbott India
about 11 hours ago20-Feb-2020 03:03:13 AM
Almost two years after he joined Abbott India Ltd (AIL) as Vice President established pharmaceuticals in an unexpected move, Jawed Zia, quit Abbott for "personal reasons".Jawed had joined the role in June 20...
Read more...
Like
reply
Reply
@newsbot • Reputation: 2,356
Buy Abbott India target of Rs 16880: ICICI Direct
ICICI Direct is bullish on Abbott India has recommended buy rating on the stock with a target price of Rs 16880 in its research report dated February 10, 2019.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,356
Experts say MNC stocks attractive as govt abolishes DDT, name 6 must buys
Investors should not avoid MNC companies as part of their portfolio largely because they are good dividend payers and also they are defensive play when volatility increases.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,356
‘Coming week could see dilly-dallying of bourses; 12,200 is important resistance level’
As the major events are already taken care of, the Street will largely be guided by global mood, which is currently highly dependent on the coronavirus outbreak, Umesh Mehta told Moneycontrol
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,356
Abbott India Q3 net profit rises 59% to Rs 187cr
Its revenue from operations stood at Rs 1,078.25 crore for the quarter under consideration as against Rs 947.65 crore for the corresponding period a year ago.
Moneycontrol
Like
reply
Reply

BRIEF-Abbott India's Dec-Quarter Profit Rises - Reuters
07-Feb-2020 02:21:42 PM
Feb 7 (Reuters) - Abbott India Ltd ABOT.NS:
DEC-QUARTER PROFIT 1.87 BILLION RUPEES VERSUS 1.17 BILLION RUPEES YEAR AGO
DEC-QUARTER REVENUE FROM OPERATIONS 10.78 BILLION RUPEES VERSUS 9.48 BILLION RUP...
Read more...
Like
reply
Reply
@newsbot • Reputation: 2,356
MNC stocks rally 1-6% after Budget 2020 scraps DDT
The FM proposed to remove the DDT and adopt the classical system of dividend taxation under which the companies would not be required to pay the tax.
Moneycontrol
Like
reply
Reply
@V3Research • Reputation: 4,951
ABBOTINDIA

Type
Buy
Instrument
ABBOTINDIA
Entry Price
₹13,040
Price@Trade
₹13,020
Target Price
₹15,100
Stop Price
₹12,300
Valid Till
Feb 6, 2020 3:20 AM
Margin
₹13,040 approx for 1 Qty
Status
Stoploss Hit
Exit Price
₹12,300
Net P&L
-5.67% Loss
Like
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Jan 6 4:33 AM

Update
Trade Entered
Entry Price
₹13,040
TrackerBot @trackerbot
Feb 1 8:48 AM

Update
Stoploss Hit
Exit Price
₹12,300

ABBOTINDIA - chart - 490773
ABBOT
Like
reply
Reply
@databot • Reputation: 2,416

ICICIdirect.com target on ABBOTINDIA
Date: 25-Nov-19 Broker: ICICIdirect.com Price @ Call: 12572.1 Target: 14600 Recommendation: BUY
Like
reply
Reply
@newsbot • Reputation: 2,356
'Market likely at new high by Dec, bet on these top 5 stocks among MNCs India Lite basket'
Instead of picking standalone stocks, it would be better to pick baskets of stocks which have a safety net and diversification to mitigate the risks.
Moneycontrol
Like
reply
Reply
Equity FnO & Crude Hub in ABBOTINDIA

10350 low made as of now 👍
Like
reply
Reply

ABBOTINDIA - chart - 406340

Like
reply
Reply
@newsbot • Reputation: 2,356
Top 30 large, mid & smallcap stocks fund managers bought, sold in September
Balanced, Liquid & Income schemes witnessed net outflow, while inflows into equity funds declined sharply in September to Rs 6,600 cr from Rs 9,150 crore in August.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,356
Indian pharma market sees growth of 11.5% in Q2FY20
The July-October period saw outbreaks of infectious diseases in many parts of the country, aiding the growth of anti-infective segment to 14 percent YoY in the second quarter, beating overall IPM growth.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,356
Indian pharma market registers growth of 11.5% in Q2FY20
The July-October period saw outbreaks of infectious diseases in many parts of the country, aiding the growth of anti-infective segment to 14 percent YoY in the second quarter, beating overall IPM growth.
Moneycontrol
Like
reply
Reply

ABBOTINDIA - chart - 369949
Abbot
Like
reply
Reply
@databot • Reputation: 2,416

ICICIdirect.com Recommendation on ABBOTINDIA
Date: 26-Aug-19 Broker: ICICIdirect.com Price @ Call: 8799.1 Target: 10190 Recommendation: BUY
Like
reply
Reply

ABBOTINDIA - chart - 309269
Abbot
Like
reply
Reply
@guptan • Reputation: 3,188

ABBOTINDIA - chart - 306152
Abbot
Like
reply
Reply
@newsbot • Reputation: 2,356
Like
reply
Reply
@newsbot • Reputation: 2,356
Like
reply
Reply
@guptan • Reputation: 3,188

ABBOTINDIA - chart - 254591
Abott
Like
reply
Reply
@newsbot • Reputation: 2,356
Like
reply
Reply

Abbot
ABBOTINDIA - chart - 215897
Like
reply
Reply
@newsbot • Reputation: 2,356
Like
reply
Reply
@newsbot • Reputation: 2,356
Like
reply
Reply
@newsbot • Reputation: 2,356
Like
reply
Reply
@newsbot • Reputation: 2,356
Like
reply
Reply
@newsbot • Reputation: 2,356
Like
reply
Reply
@newsbot • Reputation: 2,356
Like
reply
Reply
@newsbot • Reputation: 2,356
Like
reply
Reply
@newsbot • Reputation: 2,356
Like
reply
Reply
@newsbot • Reputation: 2,356
Like
reply
Reply
  • ABBOTINDIA - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization15,505.81
    Enterprise Value13,821.52
    Price to Earnings28.88
    Price to Book Value7.72
    Return on Capital Employed0.37
    Return on Equity0.24
    Face Value10
    Dividend Yield0.01
  • ABBOTINDIA Share Price - Technicals

    keyboard_arrow_down
    ABBOTINDIA - 52 Week High₹16,499
    ABBOTINDIA - 52 Week Low₹7,160
  • ABBOTINDIA - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    25-Nov-19ICICIdirect.comBuy14,600
    26-Aug-19ICICIdirect.comBuy10,190
    12-Oct-18CentrumHold7,250
    20-Dec-17ICICIdirect.comBuy6,850
    6-Feb-17CentrumBuy5,380
    ABBOTINDIA Brokerage Price Target
  • ABBOTINDIA Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Feb 27163361645016011.2516185.1
    Feb 2616201164991595016237.1
    Feb 25160001624915970.6516202.65
    Feb 241579916279.91540015943.9
    Feb 201580015984.1515400.115527.65
  • ABBOTINDIA Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹14,511.61
    30 Day Moving Average₹13,891.56
    50 Day Moving Average₹13,518.67
    100 Day Moving Average₹12,749.27
    200 Day Moving Average₹10,777.94
  • ABBOTINDIA - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue3,2992,902.560.14
    Operating Profit525397.310.32
    Profit Before Tax621436.490.42
    Net Income401276.650.45
  • ABBOTINDIA - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds2,0081,6930.19
    Total Liabilities9327350.27
    Total Assets2,9412,4280.21
  • ABBOTINDIA - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity153307.22-0.5
    Cash from Investing Activity-215-155.410.38
    Cash from Financing Activity-102-89.760.14
    Net Cash Flow-16562.05-3.66
  • ABBOTINDIA - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.170.13
    Return on Equity0.240.2
    Return on Capital Employed0.370.32
  • ABBOTINDIA - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.28
    3 Year CAGR Growth in Operating Profit0.49
    3 Year CAGR Growth in EBIDTA0.44
    3 Year CAGR Growth in Net Income0.39
    3 Yr CAGR Growth - Diluted EPS0.39
  • ABBOTINDIA - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.01
    5 Year CAGR Growth in Operating Profit2.04
    5 Year CAGR Growth in EBIDTA1.33
    5 Year CAGR Growth in Net Income1.3
    3 Yr CAGR Growth - Diluted EPS1.3
  • ABBOTINDIA - Recent News

    keyboard_arrow_down
    NewsBot
    Feb 26 3:38 AM
    Value investing: Top 10 stocks based on Warren Buffett's investment methodology
    Moneycontrol
    NewsBot
    Feb 11 8:58 AM
    Buy Abbott India target of Rs 16880: ICICI Direct
    Moneycontrol
    NewsBot
    Feb 11 3:48 AM
    Experts say MNC stocks attractive as govt abolishes DDT, name 6 must buys
    Moneycontrol
    NewsBot
    Feb 9 2:23 AM
    ‘Coming week could see dilly-dallying of bourses; 12,200 is important resistance level’
    Moneycontrol
    NewsBot
    Feb 7 1:23 AM
    Abbott India Q3 net profit rises 59% to Rs 187cr
    Moneycontrol
    NewsBot
    Feb 3 11:13 AM
    MNC stocks rally 1-6% after Budget 2020 scraps DDT
    Moneycontrol
    NewsBot
    Oct 24 5:28 AM
    'Market likely at new high by Dec, bet on these top 5 stocks among MNCs India Lite basket'
    Moneycontrol
    NewsBot
    Oct 16 3:38 AM
    Top 30 large, mid & smallcap stocks fund managers bought, sold in September
    Moneycontrol
    NewsBot
    Oct 9 1:38 AM
    Indian pharma market sees growth of 11.5% in Q2FY20
    Moneycontrol
    NewsBot
    Oct 9 11:08 AM
    Indian pharma market registers growth of 11.5% in Q2FY20
    Moneycontrol
  • ABBOTINDIA - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. S...
    Aurobindo Pharma Ltd. Sector: Pharma...
    Biocon Ltd. Sector: Pharmaceuticals ...
    Cipla Ltd. Sector: Pharmaceuticals a...
    Dr. Reddy's Laboratories Ltd. Sector...
    Lupin Ltd. Sector: Pharmaceuticals an...
    Piramal Enterprises Ltd. Sector: Phar...
    Divi's Laboratories Ltd. Sector: Pha...
    Glenmark Pharmaceuticals Ltd. Sector...
    Strides Pharma Science Ltd. Sector: P...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.